Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities

Development of novel vaccines and improving existing vaccines is critical to addressing areas of unmet or under-addressed health needs globally and to improving existing vaccination coverage and equity. However, vaccine innovation is costly and highly complex. To understand how vaccine manufacturers...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayman, Benoit, Bowles, Alex, Evans, Beth, Eyermann, Elizabeth, Nepomnyashchiy, Lyudmila, Pagliusi, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909323/
https://www.ncbi.nlm.nih.gov/pubmed/33487466
http://dx.doi.org/10.1016/j.vaccine.2020.12.085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909323/
https://www.ncbi.nlm.nih.gov/pubmed/33487466
http://dx.doi.org/10.1016/j.vaccine.2020.12.085

Ejemplares similares